Geode Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.6M Buy
6,189,058
+220,760
+4% +$380K ﹤0.01% 2327
2025
Q1
$19.9M Buy
5,968,298
+96,878
+2% +$323K ﹤0.01% 1905
2024
Q4
$43.5M Buy
5,871,420
+222,425
+4% +$1.65M ﹤0.01% 1511
2024
Q3
$53.1M Sell
5,648,995
-137,537
-2% -$1.29M ﹤0.01% 1390
2024
Q2
$46.4M Buy
5,786,532
+279,915
+5% +$2.25M ﹤0.01% 1412
2024
Q1
$81.6M Buy
5,506,617
+469,519
+9% +$6.96M 0.01% 1059
2023
Q4
$41M Buy
5,037,098
+287,687
+6% +$2.34M ﹤0.01% 1466
2023
Q3
$21.6M Buy
4,749,411
+611,049
+15% +$2.78M ﹤0.01% 1772
2023
Q2
$29.1M Buy
4,138,362
+1,098,929
+36% +$7.74M ﹤0.01% 1612
2023
Q1
$18.6M Buy
3,039,433
+233,052
+8% +$1.42M ﹤0.01% 1854
2022
Q4
$17.9M Buy
2,806,381
+134,223
+5% +$858K ﹤0.01% 1838
2022
Q3
$25.6M Buy
2,672,158
+32,269
+1% +$309K ﹤0.01% 1556
2022
Q2
$29.1M Buy
2,639,889
+741,702
+39% +$8.19M ﹤0.01% 1491
2022
Q1
$31.6M Buy
1,898,187
+50,376
+3% +$839K ﹤0.01% 1578
2021
Q4
$35.3M Buy
1,847,811
+61,799
+3% +$1.18M ﹤0.01% 1573
2021
Q3
$44M Sell
1,786,012
-43,224
-2% -$1.07M 0.01% 1389
2021
Q2
$47.6M Buy
1,829,236
+106,413
+6% +$2.77M 0.01% 1353
2021
Q1
$54.5M Buy
1,722,823
+62,962
+4% +$1.99M 0.01% 1160
2020
Q4
$77M Buy
1,659,861
+94,876
+6% +$4.4M 0.01% 822
2020
Q3
$51.5M Sell
1,564,985
-36,161
-2% -$1.19M 0.01% 897
2020
Q2
$44M Sell
1,601,146
-171,223
-10% -$4.7M 0.01% 964
2020
Q1
$53.1M Buy
1,772,369
+115,311
+7% +$3.45M 0.01% 744
2019
Q4
$45.9M Buy
1,657,058
+77,657
+5% +$2.15M 0.01% 1002
2019
Q3
$28.7M Sell
1,579,401
-53,155
-3% -$967K 0.01% 1237
2019
Q2
$40M Buy
1,632,556
+159,148
+11% +$3.9M 0.01% 1011
2019
Q1
$14M Buy
1,473,408
+128,706
+10% +$1.22M ﹤0.01% 1667
2018
Q4
$11.9M Buy
1,344,702
+466,218
+53% +$4.13M ﹤0.01% 1673
2018
Q3
$9.88M Buy
878,484
+118,176
+16% +$1.33M ﹤0.01% 1927
2018
Q2
$9.73M Buy
760,308
+103,594
+16% +$1.33M ﹤0.01% 1881
2018
Q1
$11.1M Buy
656,714
+82,671
+14% +$1.4M ﹤0.01% 1695
2017
Q4
$4.59M Buy
574,043
+49,151
+9% +$393K ﹤0.01% 2259
2017
Q3
$4.07M Buy
524,892
+7,244
+1% +$56.1K ﹤0.01% 2330
2017
Q2
$3.8M Buy
517,648
+16,884
+3% +$124K ﹤0.01% 2329
2017
Q1
$3.73M Buy
500,764
+142,298
+40% +$1.06M ﹤0.01% 2277
2016
Q4
$2.49M Buy
358,466
+13,507
+4% +$93.9K ﹤0.01% 2514
2016
Q3
$2.84M Buy
344,959
+21,604
+7% +$178K ﹤0.01% 2337
2016
Q2
$2.62M Buy
323,355
+3,596
+1% +$29.1K ﹤0.01% 2305
2016
Q1
$1.62K Buy
319,759
+15,638
+5% +$79 ﹤0.01% 2596
2015
Q4
$2.35M Buy
304,121
+8,423
+3% +$65K ﹤0.01% 2367
2015
Q3
$1.7M Buy
295,698
+28,818
+11% +$166K ﹤0.01% 2547
2015
Q2
$2.45M Buy
+266,880
New +$2.45M ﹤0.01% 2370